Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

KalVista Pharmaceuticals Inc (F: 4XC1)

 
4XC1 Technical Analysis
4
As on 10th Jul 2023 4XC1 STOCK Price closed @ 9.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 10.59 & Strong Sell for SHORT-TERM with Stoploss of 12.94 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4XC1STOCK Price

Open 9.20 Change Price %
High 9.60 1 Day 1.50 18.52
Low 9.20 1 Week 1.30 15.66
Close 9.60 1 Month 0.05 0.52
Volume N/A 1 Year -1.20 -11.11
52 Week High 16.55 | 52 Week Low 4.23
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
4XC1
Daily Charts		 4XC1
Intraday Charts		 Whats New @
Bazaartrend		 4XC1
Free Analysis
 
4XC1 Important Levels Intraday
RESISTANCE10.37
RESISTANCE10.12
RESISTANCE9.97
RESISTANCE9.82
SUPPORT9.38
SUPPORT9.23
SUPPORT9.08
SUPPORT8.83
 
4XC1 Forecast May 2024
Share
4th UP Forecast18.46
3rd UP Forecast15.62
2nd UP Forecast13.86
1st UP Forecast12.11
1st DOWN Forecast7.09
2nd DOWN Forecast5.34
3rd DOWN Forecast3.58
4th DOWN Forecast0.74
 
4XC1 Weekly Forecast
4th UP Forecast12.88
3rd UP Forecast11.83
2nd UP Forecast11.18
1st UP Forecast10.53
1st DOWN Forecast8.67
2nd DOWN Forecast8.02
3rd DOWN Forecast7.37
4th DOWN Forecast6.32
 
4XC1 Forecast2024
4th UP Forecast33.34
3rd UP Forecast25.73
2nd UP Forecast21.02
1st UP Forecast16.31
1st DOWN Forecast2.89
2nd DOWN Forecast-1.82
3rd DOWN Forecast-6.53
4th DOWN Forecast-14.14
 
 
4XC1 Other Details
Segment EQ
Market Capital 339873536.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4XC1 Address
4XC1
 
4XC1 Latest News
 
Your Comments and Response on KalVista Pharmaceuticals Inc
 
4XC1 Business Profile
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which has completed Phase II clinical trial for an oral on-demand therapy for acute HAE attacks; and KVD824, an oral product candidate for the treatment of HAE. The company is headquartered in Cambridge, Massachusetts. Address: 55 Cambridge Parkway, Cambridge, MA, United States, 02142
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service